Our Future With Artificial Intelligence

Top Pick November 21, 2019 $40.00
(Photo: MF3d/iStock)
(Photo: MF3d/iStock)

Join us at this exclusive event at a private home in Cambridge for a talk about our future with AI from leading Israeli experts.

Looking for a place to advance your professional network together with other young professionals with Israel at heart? Don’t miss out on this unique opportunity designed especially for you. Dinner and drinks are included!

This event is free for EDGE members. Want to become an EDGE member? Click here.

Daniel Serfaty, Founder and CEO, Aptima, Inc., Chairman, Aptima Ventures

As Aptima’s founder and CEO, Daniel Serfaty has led Aptima to become the premier human-centered engineering business in the world. His work optimizes the integration of humans with intelligent technologies in defense, health care, aviation and education. His keynote addresses around the world are encouraging his audiences to imagine a future in which human and artificial intelligence work together in the service of humankind. Daniel and his wife, Irene, live in Cambridge with their twins, Natasha and Gabriel. Daniel’s interdisciplinary background includes degrees in mathematics, psychology, aerospace engineering and international business management from the Université de Paris, the Technion, Israel Institute of Technology and UConn. He is the recipient of the University of Connecticut Distinguished Service Award and has been inducted into its Engineering Hall of Fame.

Ronny Shalev, Ph.D., CEO, Dyad Medical

Ronny Shalev, Ph.D., is the CEO of Dyad Medical, a start-up company in Boston. Dyad Medical develops AI applications to provide automated medical image analysis to reduce the need for human intervention and thus errors and conflicts. Dr. Shalev has spent much of the past 25 years in executive positions, including VP of marketing and sales at Orbotech (NASDAQ: ORBK), where he managed sales and marketing teams of over 100 people worldwide, and director of the World Wide Program Management at Marvell Semiconductor (NASDAQ: MRVL), where he managed development of over 200 products. Dr. Shalev obtained his BS, MS and Ph.D. degrees from Case Western Reserve University, specializing in machine learning, medical image processing and visualization.

Eila Arich-Landkof, Founder and CEO, Oriel Research Therapeutics

An entrepreneur in the computer science and life science industries, Eila Arich-Landkof served in a variety of positions in the high-tech industry and in the life-science industry. He worked for leading companies such as Cisco, Microsoft, Elbit Systems, The Whitehead Institute, Mass General and the Broad Institute. Currently, Eila leads the Deep-Learning-in-Production meetup in Cambridge (2,000+ members) and is the founder and CEO of Oriel Research Therapeutics, where AI methods are used to develop disease screening tests and therapy matching for patients.

+ More... - Less...
Fact Sheet
Thursday, November 21, 2019, 7:00 pm - 9:00 pm
Organized By

CJP provides the above links concerning third-party events for your convenience only. CJP has no control over the content of the linked-to websites or events they describe, and accepts no responsibility for the websites, including any advertising or products or services on or available from such sites, or for any loss or damage that may arise from your attending, or registering to attend, the described events. If you decide to access any of the third-party websites linked to below, you do so entirely at your own risk and subject to the terms and conditions of use for such websites and event attendance. CJP is not responsible or liable to you or any third party for the content or accuracy of any materials provided by any third parties. All statements and/or opinions expressed in the linked-to materials or at the described events, and all commentary, articles and other content provided at the third-party websites or at the events, are solely the opinions and the responsibility of the persons or entities operating the linked-to websites and events. The inclusion of any link on this website does not imply that CJP endorses the described event, or the linked-to website or its operator. MORE

More From...

More In...